Prof. Lynne Dawkins

Dr Lynne Dawkins, LSBU

Professor of Nicotine and Tobacco Studies

  • Email:
  • Telephone:
    020 7815 5422
  • School/Division:
    Applied Sciences / Psychology

Prof. Dawkins completed her PhD in 2001 and postdoctoral studies in 2006 at Goldsmiths, University of London before taking up a senior lectureship in 2006 and Readership in 2014 at the University of East London (UEL) where she co-ordinated the Drugs and Addictive Behaviours Research Group.  She joined LSBU as an Associate Professor specialising in Addictions in February 2016.

With over 20 years’ experience of working with smokers and, more recently, electronic cigarette users, Prof. Dawkins is one of the UK’s leading authorities on e-cigarettes, having published papers on profiles of use, acute effects, puffing topographies and nicotine delivery.  She has disseminated her findings widely via academic conferences, public lectures and online media and her current work is funded by Cancer Research UK and the National Institute of Health Research.   Her work attracts considerable media interest and her recent impact case study for REF2014 achieved a 100% 4* rating, joint top in the UK.

Prof. Dawkins has extensive experience of teaching and course design in Psychology at BSc and MSc levels, and has been a fellow of the Higher Education Academy (HEA) since 2012.

BSc Psychology

  • Introducing Real World Psychology
  • Psychology of Addictive Behaviour
  • Psychology of Feelings
  • Psychopharmacology
  • Psychology of Thinking and Communication

MSc Addiction Psychology and Counselling

  • Advanced Addiction Psychology

MSc Mental Health and Clinical Psychology

  • Research Methods for Mental Health

MSc Psychology

  • Emotion and Human Behaviour

She is involved in supervising a number of BSc and MSc research projects and PhD students.

Acute and chronic effects of tobacco smoking

Dr Dawkins’ previous studies were among the first to demonstrate that smokers show impaired reward responsiveness and response inhibition during acute abstinence from smoking - effects that can be reversed following nicotine administration. In a larger-scale prospective study of 200 smokers attempting to quit, she subsequently reported that whilst reward responsiveness improves over 3 months of successful cessation, response inhibition does not. Current research is focusing on the possible clinical utility of response inhibition training for abstinent smokers.

Electronic cigarette research

In a related line of empirical enquiry, Dr Dawkins has explored effects of various electronic delivery devices for craving reduction, cognitive functioning and blood nicotine delivery.  In a large scale survey of e-cigarette users, her team captured essential data on user profiles, preferences and utilization behaviour  and a pharmacokinetic study was the first in Europe to demonstrate measurable nicotine delivery in experienced e-cigarette users. That large individual differences in puffing technique and nicotine delivery were observed in this study has informed current research focusing on puffing topographies, self- titration and toxicant exposure.

Current projects

  • Utilisation patterns, smoking cessation and harm reduction behaviour in new users over 12 months (project leader).  If you are a new e-cigarette user interesting in participating in this study, click here:
  • E-cigarette puffing patterns associated with high and low nicotine e-liquid strength:  Effects on toxicant and carcinogen exposure (principal investigator; funded by Cancer Research UK)
  • A randomised controlled non-inferiority trial to examine the efficacy of e-cigarettes compared with standard pharmacotherapy, when used within the UK stop smoking service (co-investigator; NIHR funded trial led by Queen Mary, University of London).
  • Acceptability, patterns of use and safety of electronic cigarettes in people with mental illness: A pilot study.  (Co-investigator; project led by the Institute of Psychiatry, Kings College London).
  • Higher Education Academy (HEA) Fellow, 2012–present
  • Society for the Study of Addiction (SSA), 2007–present
  • Society for Research on Nicotine and Tobacco (SRNT), 2005–present
  • British Psychological Society (BPS) Graduate Member, 2000–present
  • British Association of Psychopharmacology (BAP), 1996–present
  • Assistant Editor:  Addiction. 2013–present
  • Reviewer (Journals): Addiction; Addictive Behaviors; Addiction Biology; Appetite; Brain Research Bulletin; Drug and Alcohol Dependence; Drugs: Education, Prevention & Policy; Harm Reduction Journal; International Journal of Drug Policy; International Journal of Environmental Research and Public Health; Journal of Clinical Psychiatry; Journal of Clinical Psychopharmacology; Journal of Studies on Alcohol and Drugs; Nicotine and Tobacco Research; Pediatrics; PLoS ONE; Psychopharmacology; Substance Abuse: Research and Treatment; The Medical Letter; Tobacco Control
  • Reviewer (Funding Councils): Cancer Research UK (CRUK); European & Social Research Council (ESRC); National Institute of Health Research (NIHR); British Heart Foundation (BHF)
  • Reviewer: Society for Research on Nicotine and Tobacco (SRNT) annual meeting abstract reviewer
  • Editor and Reviewer: for the National Centre for Smoking Cessation and Training (NCSCT) briefing on e-cigarettes (external PDF)
  • External Examiner (Buckingham New University) 2011–15
  • Invited speaker/panel member/contributor at various events including: E-cigarette summit; Society for the Study of Addiction (SSA) annual meeting; Global Forum on Nicotine annual conference; Addiction Research & Therapy conference; Parliamentary Round Table on E-Cigarettes; London Drug & Alcohol Policy Forum harm reduction discussion
  • Member of the All Party Parliamentarian Group on E-cigarettes, House of Commons
  • Member of the UK E-cigarette Research Forum, Cancer Research UK
Top of page
Related courses
Top of page